A detailed history of Gamma Investing LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 149 shares of GH stock, worth $7,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149
Previous 35 325.71%
Holding current value
$7,034
Previous $803,000 466.87%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$20.2 - $38.11 $2,302 - $4,344
114 Added 325.71%
149 $4.55 Million
Q3 2024

Oct 04, 2024

BUY
$22.3 - $36.29 $512 - $834
23 Added 191.67%
35 $803,000
Q2 2024

Jul 02, 2024

SELL
$16.07 - $31.84 $80 - $159
-5 Reduced 29.41%
12 $347,000
Q1 2024

Apr 05, 2024

BUY
$17.13 - $26.91 $119 - $188
7 Added 70.0%
17 $351,000
Q4 2023

Feb 01, 2024

BUY
$21.58 - $29.5 $215 - $295
10 New
10 $219,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.83B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.